Replies to post #8659 on Cel Sci Corporation (CVM)

[Foxwoods Man]

Additionally - if the Phase III trial enrollment only runs another 12 months,... that burn rate will drop after active enrollment of new patients ceases,... so that money could indeed last through the remainder of the Phase III waiting period.

Good point....and we MUST keep these people happy:

Basic Compensation
Name Fiscal Year Total
Geert Kersten
$3,961,640
Patricia Prichep
$2,045,600
John Cipriano
$1,127,550
Daniel Zimmerman
$459,855
Eyal Talor
$2,075,880

Salary and stock options...

[woolrich]

Why would ErgoMed commit $2,000,000 more, on top of their already committed $10,000,000 if they did not believe in Multikine?

The only way ErgoMed can make their money back is if Multikine is approved.